Green sustainable assessment of stability indicating first derivative synchronous fluorimetry for determination of anti-diabetic drug with its toxic impurity

Alam, 2020, Quantitative determination of canagliflozin in human plasma samples using a validated HPTLC method and its application to a pharmacokinetic study in rats, Biomed. Chromatogr., 34, 1, 10.1002/bmc.4929 Donakonda, 2021, A rapid RP-HPLC method for the simultaneous estimation of Ivacaftor and Tezacaftor and in silico study of their metabolitic products, Futur J Pharm Sci, 7, 2, 10.1186/s43094-021-00254-y El-Gamal, 2018, Stability indicating 1st derivative synchronous spectrofluorimetric method for the determination of the newly approved antiviral drug daclatasvir in presence of its oxidative and photolytic degradation products: application to tablet dosage form, Pharm. Anal. Acta, 2 Elzanfaly, 2017, Zero and second-derivative synchronous fluorescence spectroscopy for the quantification of two non-classical β-lactams in pharmaceutical vials: application to stability studies, Luminescence, 32, 1517, 10.1002/bio.3353 Emam, 2018, Canagliflozin stability study and ecofriendly chromatographic determination of its degradation product: a comparative study, J. Separ. Sci., 41, 822, 10.1002/jssc.201700976 Emam, 2019, Stability-indicating chromatographic and chemometric methods for environmentally benign determination of canagliflozin and its major degradation product; A comparative study and greenness assessment, Biomed. Chromatogr., 33, 1, 10.1002/bmc.4612 Emam, 2023, Ecofriendly appraisal of stability‐indicating high‐performance chromatographic assay of canagliflozin and metformin with their toxic impurities; in silico toxicity prediction, J. Separ. Sci., 46, 1, 10.1002/jssc.202200754 Fares, 2021, Spectrouorimetric approach for quantication of cyclizine in the presence of its toxic impurities in human plasma; in silico study and ADMET calculations, Res. square, 1 Gałuszka, 2012, Analytical Eco-Scale for assessing the greenness of analytical procedures, Trac. Trends Anal. Chem., 10.1016/j.trac.2012.03.013 Hariharan, 2022, The dietary inflammatory index, obesity, type 2 diabetes, and cardiovascular risk factors and diseases, Obes. Rev., 10.1111/obr.13349 2005 Kaur, 2016, Development and validation of stability indicating UV spectroscopic method for determination of canagliflozin in bulk and pharmaceutical dosage form, Pharm Methods, 7, 63, 10.5530/phm.2016.7.10 Kaur, 2016, Development and validation of a stability-indicating high performance thin layer chromatography (HPTLC) method for estimation of canagliflozin in bulk and pharmaceutical dosage form, J. Appl. Pharmaceut. Sci., 6, 51, 10.7324/JAPS.2016.60508 Kumar Parida, 2018, RP-HPLC method for the estimation of canagliflozinin bulk and pharmaceutical dosage forms, international journal of pharma research and health sciences, 6, 2308 Kumar, 2020, A review on diabetes mellitus: type1 & type2 a review on β-ESCIN view project anti-ulcer activity view project, World J. Pharm. Pharmaceut. Sci., 9, 838 Meininger, 2015, Canagliflozin for the treatment of adults with Type 2 diabetes, Diabetes Manag., 5, 183, 10.2217/dmt.15.11 Nirav, 2019, Development and validation of spectrofluorimetric method the estimation of canagliflozin in its pharmaceutical dosage form, International J. Pharm.ceutical Sci., 10, 147 Olokoba, 2012, Type 2 diabetes mellitus: a review of current trends, Oman Med. J., 27, 269, 10.5001/omj.2012.68 Pachore, 2017, Synthesis and characterization of potential impurities of canagliflozin, ChemistrySelect, 2, 9157, 10.1002/slct.201701973 Padma, 2019, Review on strategies and analytical perspectives of stability indicating assay methods (SIAMS), Int. J. Pharm. Pharmaceut. Res., 16, 408 Pathak, 2018, Development and validation of UV-spectroscopy based stability indicating different methods for the determination of Canagliflozin, J. Indian Chem. Soc., 95, 459 Pauli, 2014, Importance of purity evaluation and the potential of quantitative 1 H NMR as a purity assay, J. Med. Chem., 57, 9220, 10.1021/jm500734a Pena-Pereira, 2020, Agree - analytical GREEnness metric approach and software, Anal. Chem., 92, 10076, 10.1021/acs.analchem.0c01887 Pires, 2015, pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures, J. Med. Chem., 58, 4066, 10.1021/acs.jmedchem.5b00104 Pooja, 2018, Development and validation of UV spectrophotometric method for the estimation of canagliflozin in bulk and pharmaceutical dosage form, Int. J. Pharm. Pharmaceut. Res., 13, 1 Ramzy, 2022, Application of green first derivative synchronous spectrofluorometric method for quantitative analysis of fexofenadine hydrochloride and pseudoephedrine hydrochloride in pharmaceutical preparation and spiked human plasma, BMC Chem., 16, 2, 10.1186/s13065-022-00855-5 Reddy, 2020, Development and validation of reverse phase high performance liquid chromatography method for the estimation of canagliflozin in bulk and its pharmaceutical formulation, J. Young Pharm., 12, 321, 10.5530/jyp.2020.12.85 Rosenthal, 2015, Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus, Ann. N. Y. Acad. Sci., 1358, 28, 10.1111/nyas.12852 Singh, 2019, New analytical method development and validation of canagliflozin (anti-diabetic) drug by RP-HPLC method in bulk and pharmaceutical dosage form, Int. J. Res. Anal Rev.(IJRAR), 6, 632 Suneetha, 2015, A validated stability indicating RP-HPLC method for estimation of canagliflozin in dosage form, Res. J. Pharmaceut. Biol. Chem. Sci., 6, 1186